A R T I C L E S
Pellegrino et al.
obtained. FeIII(TFPPBr8)Cl assembles the ease of preparation
and a highly positive shifted FeIII/FeII reduction potential (+600
mV from FeTPP).15 In this contribution, we describe the
preparation, isolation, and spectroscopic characterization of a
{FeNO}8 complex, [Co(C5H5)2]+[Fe(TFPPBr8)NO]- (2), ob-
tained from reduction of 1 with the one-electron reductant
cobaltocene. The electronic structure of the new complex was
assessed by DFT calculations.
2. Experimental Section
2.1. Syntheses. 5,10,15,20-[Tetrakis-(pentafluorophenyl)]por-
phyrin (H2TFPP) was purchased from Frontier Scientific and used
as received. All other reagents were used as received, except
Co(C5H5)2 (Sigma-Aldrich) that was sublimed prior to use. All
solvents were distilled and dried according to conventional proce-
dures. The porphyrin ligand TFPPBr8 and its iron(III) complex
FeIII(TFPPBr8)Cl were prepared according to slightly modified
published procedures, starting from H2TFPP.16
Figure 1. [FeIII(TFPPBr8)]+.
octaethyl-5,10,15,20-[Tetrakis-(phenyl)]porphyrin) provided the
first evidence of {FeNO}8 porphyrinate complexes, in dichlo-
romethane solutions.9 Following the track, Ryan et al. prepared
[Fe(TPP)NO]- in THF solution by both electrochemical and
chemical reduction, and afforded further structural and reactivity
insight.10 Albeit the anaerobic THF solution stabilized the
{FeNO}8 species, dichloromethane solutions gave back the
{FeNO}7 precursor, with a half-life of 30 min even at low
temperatures. Further reduction allowed envisaging the presence
of a {FeNO}9 species by UV-vis, and exhaustive electrolysis
in the presence of weak acids yielded hydroxylamine and
ammonia as ultimate products.10
Stability of {FeNO}8 complexes in aqueous solutions was
first attained for a nitroxyl-myoglobin adduct, MbHNO,11 and
more recently in a series of FeII(globin) adducts by Farmer et
al.12 In these scenarios, the distal pocket residues provide extra
stabilization to the bound HNO by hydrogen-bonding. The
Mb(HNO) was fully characterized by NMR, Raman, and X-ray
absorption spectroscopies.11,13 This complex is a six-coordinate
HNO-adduct, and direct evidence of the H-N bond was obtained
by 1H NMR. Remarkably, the series of FeII(globin)HNO proteins
represent the only {FeNO}8 complexes obtained by direct trapping
of free HNO from HNO-donor compounds.12,14
Apparently, the main reason for the elusive nature of the NO-
iron complexes previously reported is the high ease of oxidation
to the stable {FeNO}7 form. In order to enhance the stabilization
of the heme model {FeNO}8 moiety without the support of a
protein environment, we focused on porphyrinates bearing
electron-withdrawing substituents, aiming to tune the reduction
potential of the heme-coordinated nitroxyl. In this work, we
have synthesized FeIII(TFPPBr8)Cl (TFPPBr8 ) 2,3,7,8,12,13,17,
18-octabromo-5,10,15,20-[Tetrakis-(pentafluorophenyl)]porphy-
rin, Figure 1) and the {FeNO}7 nitrosyl iron complex
FeII(TFPPBr8)NO (1) because it was hoped that upon one-
electron reduction a fairly stable {FeNO}8 complex would be
2.1.1. Fe(TFPPBr8)NO (1). This complex was prepared by
reductive nitrosylation17 of FeIII(TFPPBr8)Cl. NO was bubbled
through a solution of FeIII(TFPPBr8)Cl (50 mg; 0.03 mmol) in
degassed dichloromethane (10 mL) and methanol (5 mL) under a
nitrogen atmosphere. NO was generated by dropwise addition of a
solution of 500 mg of NaNO2 in 8 mL of degassed water to a
solution of 2.2 g of FeSO4 ·7H2O and 1 mL of H2SO4 in 15 mL of
degassed water. NO was passed through a KOH column to remove
higher oxides. The reaction was followed by UV-vis spectroscopy.
The dilute solutions of FeIII(TFPPBr8)Cl were brownish yellow,
while those of 1 were greenish yellow. The reaction was easily
followed by the shift of the Soret band from 402-442 to 430 nm.
When maximum transformation was achieved, the solvent was
removed in Vacuo, and the product was purified by column
chromatography in a drybox (stationary phase: acid alumina; mobile
phase: anhydrous and degassed CH2Cl2); the first fraction was
collected, the solvent was evaporated, and the solid residue was
dried under vacuum. Yield: 0.030 g (60%). Anal. Calcd. for
C44N5OFeBr8F20: C, 31.28; H, 0; N, 4.15. Found: C, 31.2; H, not
detected; N, 4.3. UV-vis [CH2Cl2]: λmax (ε/104) ) 430 nm (10.6),
580 nm (1.37). IR (cm-1) (KBr pellet): νNO ) 1726, isotope shift
for the 15N(O)-labeled compound: -31 cm-1
.
2.1.2. [Co(Cp)2]+[Fe(TFPPBr8)NO]- (2). Co(Cp)2 was sub-
limed by heating at no more than 60 °C, under vacuum (0.1 mmHg),
and kept and manipulated in a drybox. In a typical experiment, a
solution of Co(Cp)2 of known concentration was achieved by
dissolving 10 mg of the freshly sublimed reagent in anhydrous
CH2Cl2 to a final volume of 1 mL. In a drybox, one equivalent of
the dissolved Co(Cp)2 was added (approximately 100 µL) to a
solution of 8 mg of 1 in 100 µL of anhydrous CH2Cl2. The product,
which precipitated after the addition of 3 mL of cold hexane, was
separated from the solution by centrifugation, and the solid was
dried under vacuum. Isolated yield: 90%. Anal. Calcd for
C54H10Br8F20N5OFeCo: C, 34.52; N, 3.73; H, 0.54. Found: C: 34.6;
N, 3.6; H, 0.7. UV-vis [CH2Cl2]: λmax (ε/104) ) 430 nm (8.14),
580 nm (1.65). IR (cm-1) (solid film or CH2Cl2 solution): νNO
)
1
1550 (sh). H NMR (CD2Cl2): 4.94 (br s, 10H, [CoC10H10]+). 15N
NMR (CD2Cl2): 790 (s, br) (vs CH3NO2).
(9) (a) Lancon, D.; Kadish, K. M. J. Am. Chem. Soc. 1983, 105, 5610–
5617. (b) Olson, L.; Schaeper, D.; Lancon, D.; Kadish, K. M. J. Am.
Chem. Soc. 1982, 104, 2042–2044.
2.1.3. Synthesis of 15N(O)-Labeled 1 and 2. Fe(TFPPBr8)15NO
was prepared as described above, using 15NO prepared from
Na15NO2; [Co(Cp)2]+[Fe(TFPPBr8)15NO]- was prepared in a man-
(10) Choi, I. K.; Liu, Y.; Feng, D.; Paeng, K. J.; Ryan, M. D. Inorg. Chem.
1991, 30, 1832–1839.
(11) Lin, R.; Farmer, P. J J. Am. Chem. Soc. 2000, 122, 2393–2394.
(12) Kumar, M. R.; Pervitsky, D.; Chen, L.; Poulos, T.; Kundu, S.;
Hargrove, M. S.; Rivera, E. J.; Diaz, A.; Colo´n, J. L.; Farmer, P. J.
Biochemistry 2009, 48, 5018–5025.
(15) Grinstaff, M. W.; Hill, M. G.; Birnbaum, E. R.; Schaefer, W. P.;
Labinger, J. A.; Gray, H. B. Inorg. Chem. 1995, 34, 4896–4902.
(16) (a) Birnbaum, E. R.; Hodge, J. A.; Grinstaff, M. W.; Schaefer, W. P.;
Henling, L.; Labinger, J. A.; Bercaw, J. E.; Gray, H. B. Inorg. Chem.
1995, 34, 3625–3632. (b) Adler, A. D.; Longo, F. R.; Kampas, F.;
Kim, J. J. Inorg. Nucl. Chem. 1970, 32, 2443–2445.
(13) Immoos, C. E.; Sulc, F.; Farmer, P. J.; Czarnecki, K.; Bocian, D. F.;
Levina, A.; Aitken, J. B.; Armstrong, R. S.; Lay, P. A. J. Am. Chem.
Soc. 2005, 127, 814–815.
(14) Sulc, F.; Immoos, C. E.; Pervitsky, D.; Farmer, P. J. J. Am. Chem.
Soc. 2005, 126, 1096–1101.
(17) Wayland, B. B.; Olson, L. W. J. Am. Chem. Soc. 1974, 96, 6037–
6041.
9
990 J. AM. CHEM. SOC. VOL. 132, NO. 3, 2010